NDC 49281-026 – Nuvaxovid 2026-27
Nvx-cov2928 5 ug/.5mL · Injection, Suspension · Intramuscular
Product NDC49281-026
Product details
- Brand name
- Nuvaxovid 2026-27
- Generic name
- Nvx-cov2928
- Labeler
- Sanofi Vaccines US Inc.
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125817
- Marketed since
- August 27, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Nvx-cov2928 5 ug/.5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49281-026-50 | 10 SYRINGE in 1 CARTON (49281-026-50) / .5 mL in 1 SYRINGE (49281-026-88) | Aug 27, 2026 |